A projected 18% increase in insurance company asbestos losses was announced yesterday by A.M. Best. Some of us are not surprised. Indeed,...

Science, law and mass torts are increasingly intersecting and driving change.  The cancer research and medical communities are currently...

The future continues to arrive, and part of it is toxicoepigenetics. This week’s Toxicoepigenetics workshop in the DC area should be...

Last week brought $88 million of losses for insurers and others in “talc” verdicts. A recent talk by Peyton Manning to insurance...

A post from defense lawyers evaluates the March 2016 decision in Davis v. Honeywell Int’l Inc., 199 Cal.Rptr.3d 583 (Cal. Ct. App. 2016)....

A new publication on cancer includes wonderful graphics explaining how cancers escape the attention of the immune system.  A picture is...

Formaldehyde – is it the next asbestos? An interesting article on the topic is online here; it’s by Michael J. Crist

Why should mass tort stakeholders care about toxicoepigenetics?  The start of the explanation is provided in an article online here; it...

An interesting open access paper in the BJM discusses the process of and some values of a hospital using a multidisciplinary team to...

A friend let me know the following humor appeared this week on The Insurance Insider, along with some praise for Praedicat and its...

MesobanK UK published the chart as part of its September 2016 update. It’s good to see more progress in gathering samples and data. See...

The Mesothelioma Foundation’s next Symposium stop is Chicago on October 7. As they explain at the web site at curemeso.org: “So far this...

Today is Mesothelioma Day. It’s a day to regret so many unintended deaths, and to invest in research to stop or slow the disease. It’s...

Deeply understanding interactions between genes is one of the next frontiers for molecular researchers. As a result of 15 years of work,...

Definitions matter when it comes to defining “asbestos,” and the facts matter when parties are arguing about causes (or not) of...

Expert scientific reports are a staple of mass tort claiming, but are seldom the subject of detailed national media attention. Thus, it’s...

A reminder:  The focus on science keeps increasing for people in asbestos litigation. As yet another example, Cardno ChemRisk is...

This week, the Missouri legislature failed to pass a Daubert bill needed to override a prior veto by the state’s governor. The U.S....

The focus on science keeps increasing for people in asbestos litigation. As yet another example, Cardno ChemRisk is presenting a free...

Back in 2008, this blog started up because of my view that new and increasing intersections between science and law would drive many...